Quantifying risk of bleeding with post-MI anti-thrombotics

By  |  December 11, 2009 | 

In this retrospective analysis of 40,812 patients hospitalized with an MI, researchers analyzed the risk of bleeding-related hospitalizations according to different anti-thrombotic medication regimens (combinations of ASA, clopidogrel, and vitamin K antagonists). After a mean follow up of 1.3 years, the overall risk of bleeding-related hospitalizations was 5%. The annual risk for all monotherapy groups, the ASA+clopidogrel, and the ASA+vitamin K antagonist groups were between 3-5%, but was 12% for the clopidogrel + vitamin K and the triple therapy groups. The most common non-fatal bleeding was GI, and the most fatal bleeding was related to femoral pseudoaneurysms. This study helps quantify the risks of bleeding-related re-hospitalizations in patients being discharged on anti-thrombotic combinations (abstract)

Leave A Comment

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.


Related Posts

By  | June 18, 2018 |  0
Fill in the Blanks: Q: “The diagnosis of type 2 MI is associated with a _____ prognosis.  ___% of patients will live five years after their diagnosis.” The answer is a) POOR and b) a staggering 40%. I did not know that. However, what I am aware of is the ambiguity around Type 2 MIs and […]
By  | July 5, 2016 |  0
What comes to mind when you think of getting CME? I bet most of you would say sitting in an auditorium, whether that be during your local grand rounds or at our professional society meeting, like Hospital Medicine 16 in sunny San Diego this past March. Hanging out in the Twitterverse? Probably not so much… […]
By  | December 3, 2013 |  1
As a nurse practitioner in hospital medicine I have multiple opportunities to interact with all sorts of physician hospitalist colleagues, hospital medicine group leaders, quality officers etc.  Often their interactions with me take on a certain wary curiosity, like I am some exotic monkey or another creature that is unfamiliar to them.  If I am […]